Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $50.2M invested in Corvus Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 47 → 47 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Holders
47
Holding in Top 10
1
Calls
$111K
Puts
$65K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.87M | |
| 3 | +$330K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$286K |
| 5 |
Morgan Stanley
New York
|
+$175K |
Top Sellers
| 1 | -$643K | |
| 2 | -$177K | |
| 3 | -$144K | |
| 4 |
Renaissance Technologies
New York
|
-$133K |
| 5 |
Two Sigma Advisers
New York
|
-$130K |